Topic: FDA

Proposed House Bill Would Legalize CBD in Dietary Supplements and Reduce Uncertainty Surrounding CBD

Last Friday, a bipartisan bill was introduced in the House of Representatives that would legalize cannabidiol (CBD) and other hemp-derived products for use in dietary supplements. The bill—H.R. 8179—was co-sponsored by Rep. Kurt Schrader (D-OR) and Rep. Morgan Griffith (R-VA) and is referred to as the “Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020.”

Read More

FDA Still Struggling for Reliable CBD Data; Congress Losing Patience

In late May 2019, the Food and Drug Administration held a landmark hearing regarding a regulatory framework for CBD products. By July, Congress was already becoming impatient with the lack of progress. It is now January 2020, and the FDA does not appear to be much closer to releasing its long-anticipated regulations. Congress’s impatience has now turned into action.

Read More

CBD Industry Continues to Struggle With Product Content and Labeling

Last week, the Center for Food Safety (a national non-profit public interest and environmental advocacy organization) released the results of a recent study that identified some disturbing findings about the CBD industry. According to the study, nearly half of the 40 companies surveyed received failing or near-failing grades (Ds and Fs) for “their production and processing methods, testing protocols, and transparency to consumers.”

Read More

Topics

Jurisdictions

Archives

Legalized Marijuana Map

Click here to view our Legalized Marijuana Map

The Joint Status Report Podcast


Email the Editors

Click here to Email the Editors

Locke Lord LLP

For the latest information about our Firm visit lockelord.com